Eur Rev Med Pharmacol Sci 2022; 26 (9): 3061-3061
DOI: 10.26355/eurrev_202205_28722

Reply Letter – Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?

J.F. de Carvalho, L.C. Behrmann Martins, A.F. Cardoso, Y. Shoenfeld

Institute for Health Sciences from Federal University of Bahia, Salvador, BA, Brazil. jotafc@gmail.com

Free PDF Download

To cite this article

J.F. de Carvalho, L.C. Behrmann Martins, A.F. Cardoso, Y. Shoenfeld
Reply Letter – Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 9
Pages: 3061-3061
DOI: 10.26355/eurrev_202205_28722

Keywords Related articles:

  1. Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
  2. Relapsing polychondritis associated with heart block
  3. Relapsing polychondritis following silicone breast implant: first description
  4. The theory of a “staphylococcus superantigen” in chronic rhinosinusitis with nasal polyps: myth or reality?
  5. Vitamin D insufficiency is very frequent and linked to inflammatory biomarkers in relapsing polychondritis